(Total Views: 666)
Posted On: 11/09/2021 7:38:37 PM
Post# of 148899
Re: nmbr1stckpckr #110210
a pattern ive noticed usually remdesivir first maybe next tocilizumab followed by a few others usually for severe cases.then when all else fails maybe the patient gets LL IF LUCKY ?
check out the trodelvy pricing immunomedics set up for tnbc back in april 2020 and pretty much in line with the gilead pricing today.makes leronlimab the bargain of the century.imo
Immunomedics Inc. shares (NASDAQ:IMMU) were trading at $26.96, up $4.99, or 22%, on the approval yesterday of the antibody-drug conjugate Trodelvy (sacituzumab govitecan-hziy) to treat metastatic triple-negative breast cancer. Trodelvy, to be launched soon, was cleared for patients who have undergone at least two prior therapies. Morris Plains, N.J.-based Immunomedics set the wholesale acquisition cost for a single-use 180-mg vial at $2,012, which equates to $16,096 per 21-day cycle for a 70-kg person. Officials outlined marketing plans during a conference call with investor
https://www.goodrx.com/trodelvy
check out the trodelvy pricing immunomedics set up for tnbc back in april 2020 and pretty much in line with the gilead pricing today.makes leronlimab the bargain of the century.imo
Immunomedics Inc. shares (NASDAQ:IMMU) were trading at $26.96, up $4.99, or 22%, on the approval yesterday of the antibody-drug conjugate Trodelvy (sacituzumab govitecan-hziy) to treat metastatic triple-negative breast cancer. Trodelvy, to be launched soon, was cleared for patients who have undergone at least two prior therapies. Morris Plains, N.J.-based Immunomedics set the wholesale acquisition cost for a single-use 180-mg vial at $2,012, which equates to $16,096 per 21-day cycle for a 70-kg person. Officials outlined marketing plans during a conference call with investor
https://www.goodrx.com/trodelvy
(3)
(0)Scroll down for more posts ▼
